Home/Filings/4/0000950170-25-043849
4//SEC Filing

Zeiher Bernhardt G 4

Accession 0000950170-25-043849

CIK 0001658551other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:15 PM ET

Size

4.7 KB

Accession

0000950170-25-043849

Insider Transaction Report

Form 4
Period: 2025-03-20
Transactions
  • Purchase

    Common Stock

    2025-03-20$3.70/sh+10,000$37,00510,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Documents

1 file

Issuer

Amylyx Pharmaceuticals, Inc.

CIK 0001658551

Entity typeother

Related Parties

1
  • filerCIK 0001971421

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:15 PM ET
Size
4.7 KB